Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma.

Pattani KM, Soudry E, Glazer CA, Ochs MF, Wang H, Schussel J, Sun W, Hennessey P, Mydlarz W, Loyo M, Demokan S, Smith IM, Califano JA.

PLoS One. 2012;7(9):e45534. doi: 10.1371/journal.pone.0045534. Epub 2012 Sep 24.

2.

MAGEA4 induces growth in normal oral keratinocytes by inhibiting growth arrest and apoptosis.

Bhan S, Chuang A, Negi SS, Glazer CA, Califano JA.

Oncol Rep. 2012 Oct;28(4):1498-502. doi: 10.3892/or.2012.1934. Epub 2012 Jul 25.

PMID:
22842486
3.

Dose-dependent activation of putative oncogene SBSN by BORIS.

Gaykalova D, Vatapalli R, Glazer CA, Bhan S, Shao C, Sidransky D, Ha PK, Califano JA.

PLoS One. 2012;7(7):e40389. doi: 10.1371/journal.pone.0040389. Epub 2012 Jul 5.

4.

Multidisciplinary care of international patients with cleft palate using telemedicine.

Glazer CA, Bailey PJ, Icaza IL, Valladares SJ, Steere KA, Rosenblatt ES, Byrne PJ.

Arch Facial Plast Surg. 2011 Nov-Dec;13(6):436-8. doi: 10.1001/archfacial.2011.72. No abstract available.

PMID:
22106191
5.

BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer.

Bhan S, Negi SS, Shao C, Glazer CA, Chuang A, Gaykalova DA, Sun W, Sidransky D, Ha PK, Califano JA.

Clin Cancer Res. 2011 Jul 1;17(13):4267-76. doi: 10.1158/1078-0432.CCR-11-0653. Epub 2011 May 10.

6.

Integrated, genome-wide screening for hypomethylated oncogenes in salivary gland adenoid cystic carcinoma.

Shao C, Sun W, Tan M, Glazer CA, Bhan S, Zhong X, Fakhry C, Sharma R, Westra WH, Hoque MO, Moskaluk CA, Sidransky D, Califano JA, Ha PK.

Clin Cancer Res. 2011 Jul 1;17(13):4320-30. doi: 10.1158/1078-0432.CCR-10-2992. Epub 2011 May 6.

7.

The role of MAGEA2 in head and neck cancer.

Glazer CA, Smith IM, Bhan S, Sun W, Chang SS, Pattani KM, Westra W, Khan Z, Califano JA.

Arch Otolaryngol Head Neck Surg. 2011 Mar;137(3):286-93. doi: 10.1001/archoto.2011.2.

8.

TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization.

Sun W, Liu Y, Glazer CA, Shao C, Bhan S, Demokan S, Zhao M, Rudek MA, Ha PK, Califano JA.

Clin Cancer Res. 2010 Feb 1;16(3):857-66. doi: 10.1158/1078-0432.CCR-09-2604. Epub 2010 Jan 26.

9.

Integrative discovery of epigenetically derepressed cancer testis antigens in NSCLC.

Glazer CA, Smith IM, Ochs MF, Begum S, Westra W, Chang SS, Sun W, Bhan S, Khan Z, Ahrendt S, Califano JA.

PLoS One. 2009 Dec 4;4(12):e8189. doi: 10.1371/journal.pone.0008189.

10.

Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer.

Smith IM, Glazer CA, Mithani SK, Ochs MF, Sun W, Bhan S, Vostrov A, Abdullaev Z, Lobanenkov V, Gray A, Liu C, Chang SS, Ostrow KL, Westra WH, Begum S, Dhara M, Califano J.

PLoS One. 2009;4(3):e4961. doi: 10.1371/journal.pone.0004961. Epub 2009 Mar 23.

11.

Molecular techniques and genetic alterations in head and neck cancer.

Ha PK, Chang SS, Glazer CA, Califano JA, Sidransky D.

Oral Oncol. 2009 Apr-May;45(4-5):335-9. doi: 10.1016/j.oraloncology.2008.05.015. Epub 2008 Jul 31. Review.

12.

Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice.

Glazer CA, Chang SS, Ha PK, Califano JA.

Oral Oncol. 2009 Apr-May;45(4-5):440-6. doi: 10.1016/j.oraloncology.2008.05.013. Epub 2008 Jul 31. Review.

PMID:
18674958
13.

Pathology quiz case 1. Metastatic mesothelioma involving the tongue.

Glazer CA, Waldman EH, Ansari-Lari AM, Broussard JN, Brahmer J, Tufano RP.

Arch Otolaryngol Head Neck Surg. 2006 Sep;132(9):1012, 1014-5. No abstract available.

PMID:
16982980
14.

Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO.

Kim MM, Glazer CA, Mambo E, Chatterjee A, Zhao M, Sidransky D, Califano JA.

Oral Oncol. 2006 Feb;42(2):201-7. Epub 2005 Nov 2.

PMID:
16266817
15.

Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.

Lal A, Glazer CA, Martinson HM, Friedman HS, Archer GE, Sampson JH, Riggins GJ.

Cancer Res. 2002 Jun 15;62(12):3335-9.

Supplemental Content

Loading ...
Support Center